Topic Paragraphs
Featured Topics
FDA’s Technology Modernization Action Plan
The plan describes important near-term actions that FDA is taking to modernize use of technology—computer hardware, software, data, and analytics—to advance FDA’s public health mission.
Fostering Drug Competition
Increasing the availability of generic drugs helps to create competition in the marketplace, helping make treatment more affordable and increasing access to healthcare for more patients.
Combating the Opioid Crisis
FDA takes actions to combat prescription opioid abuse.
Recalls, Market Withdrawals, & Safety Alerts
The FDA provides information gathered from press releases and other public notices about certain recalls of FDA-regulated products. Not all recalls have press releases or are posted on this website
Nov 08
American Health Packaging Issues Voluntary Nationwide Recall of Ranitidine Syrup (Ranitidine Oral Solution USP) 150 mg/10 mL Liquid Unit Dose Cups Due to the Detection of N-nitrosodimethylamine (NDMA) Impurity
Drugs
Nov 08
Med Man Issues Voluntary Nationwide Recall of Up2 Due to Presence of Undeclared Sildenafil
Drugs
Nov 08
Russ Davis Wholesale Voluntarily Recalling Products Due to Possible Health Risk
Food & Beverages
FDA Voices: Perspectives from FDA Experts
Patient Perspective Is Vital to FDA's Work
FDA considers patients the real experts when it comes to their health conditions, as illustrated in the recent rare disease disorder summit.
To Help Reduce Drug Shortages, We Need Manufacturers to Sell Quality
Drug manufacturers with very high reliability usually have a mature quality management system — purchasers should have the ability to readily identify them.
Expanding Criminal Enforcement Operations Globally to Protect Public Health
FDA’s inspections, investigations, and law enforcement operations are led by FDA's Office of Regulatory Affairs.